Previous Article | Next Article 
Journal of Virology, February 1999, p. 907-919, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Fiberless Recombinant Adenoviruses: Virus
Maturation and Infectivity in the Absence of Fiber
V.
Legrand,1
D.
Spehner,2
Y.
Schlesinger,1
N.
Settelen,1
A.
Pavirani,1 and
M.
Mehtali1,*
INSERM CJF 94/03, ETS,
Strasbourg,2 and
Transgene S.A., 67000 Strasbourg,1 France
Received 30 July 1998/Accepted 20 October 1998
 |
ABSTRACT |
In vivo targeting of therapeutic genes to specific tissues has
become a major issue in gene therapy, in particular when recombinant adenovirus vectors are used. Restriction of the viral tropism to
selected cell types requires the abrogation of the interaction between
the viral fiber and its natural cellular receptors and the introduction
of a new binding specificity into the virion. In this context,
fiberless adenoviruses are attractive vectors, since they may be used
as substrates for the insertion of a new ligand in other capsid
proteins. In this study, we confirm by using cloned full-length
adenovirus genomes with the fiber gene deleted that efficient virus
particle formation can occur in the absence of fiber. As expected, the
infectivity of such fiberless viruses was severely reduced, but it
could be only partially restored when the viruses were produced in
cells stably providing the fiber in trans. Although
incorporation of penton base into the fiberless particles was normal
and binding of the particles to the cellular integrins was functional,
several pieces of experimental evidence suggest that later steps in the
cell entry process are impaired in correlation with an incorrect
maturation of several structural proteins of the fiberless particles.
These observations support the hypothesis that the fiber protein may
have additional biological functions besides its role in cell binding.
Together with the fiber complementation cells, such fiberless vectors
constitute unique tools to investigate the role of the fiber in virus
assembly, maturation, and cell entry and to explore the possibility of
deriving gene transfer vectors with novel target specificities.
 |
INTRODUCTION |
Replication-defective human
adenoviruses are attractive candidate vectors for the direct in vivo
delivery of marker or therapeutic genes to a large variety of dividing
or postmitotic cells, including cells from highly differentiated
tissues such as liver, skeletal muscle, lung, brain, or heart (6,
13, 40). While their broad host range is considered one of the
notable advantages of adenovirus vectors, the absence of cell
specificity may also constitute a drawback in some particular
circumstances. For example, in various current cancer gene therapy
protocols, uncontrolled transduction, and hence expression, of genes
encoding immunomodulatory molecules (e.g., interleukin-2 or -12) or
cytotoxic products (e.g., thymidine kinase of herpes simplex virus type
1) may potentially be harmful to the patient (7, 22, 65).
Moreover, the overall in vivo efficiency of gene delivery may be
reduced by a significant dilution of the virus in the organism after
the transduction of nontarget cells. The development of recombinant
vectors with defined tropisms would therefore greatly improve the
safety and efficiency of some current gene therapy protocols.
The specificity and efficiency of infection by human adenoviruses is
determined by the biology of the interaction between the virus and its
target cells. This interaction involves an initial high-affinity
(Kd, 10
9 to 10
10 M)
binding of the knob portion of the viral trimeric fiber protein (28, 36) to ubiquitous cell surface receptors (14,
45). Internalization of the virus particles is subsequently
mediated through a specific interaction between the viral penton base
and cell surface integrins (41, 59). Two distinct proteins
belonging to the immunoglobulin superfamily were recently identified as the primary receptors for adenovirus serotype C fibers: the
coxsackievirus-adenovirus receptor (5, 55) and the
2
domain of the major histocompatibility complex class I molecule
(30). The ubiquitous distribution of these receptors is
primarily responsible for the broad cell tropism of the human serotype
C adenoviruses. Reciprocally, the absence or reduced expression of
these receptors has been shown to correlate with the poor sensitivity
of certain cell types (e.g., lymphocytes and smooth muscle cells) to
adenovirus transduction (31, 60). This inability of human
adenoviruses to efficiently transduce some cellular populations,
together with their lack of specificity, has stimulated increasing
efforts to redirect the adenovirus tropism from its natural receptors
to specifically selected cell surface receptors.
Until now, most attempts to alter the adenovirus tropism were based on
the use of bispecific molecules recognizing simultaneously a component
of the virus particle (e.g., penton base or fiber) and the targeted
cell surface molecule (16, 21, 57, 61, 63). Bispecific
antibodies directed to the viral penton base and to either the cellular
v integrins (61) or the CD3 molecules (63)
were shown to increase the efficiency of infection of the relatively
adenovirus-resistant endothelial or smooth muscle cells or T
lymphocytes. Such gene transfer complexes, however, are characterized by an extended tropism and not by a more restricted specificity (32). Abrogation of binding of the fiber to its natural
receptors is therefore a prerequisite for any in vivo application. This abrogation was recently indirectly achieved by the use of bispecific antibodies that simultaneously block the knob-receptor interactions and
target specific cell surface markers such as the folate receptor (16), the fibroblast growth factor-2 receptor
(21) or the epidermal growth factor receptor
(57). The major drawbacks of these strategies are the
potential clearance of the complexes by Fc receptors and the risk of
potential activation of the complement system. Moreover, the production
and use of a second molecular component is required, making such
approaches relatively complex and expensive to develop. Alternatively,
strategies based on the use of viruses whose fiber proteins have been
genetically engineered to acquire a novel binding specificity are more
attractive, since no other targeting molecular component is required.
Adenovirus type 5 (Ad5) vectors harboring the binding specificity of
Ad3 and able to transduce cells normally resistant to Ad5 were thus generated by simply replacing the Ad5 knob sequences by their homologous Ad3 sequences (35, 51, 52). Similarly, nonviral ligands (polylysine and RGD peptides) were also successfully inserted in the fiber protein, generating viruses with extended tropism (60, 64). However, the interaction of these virus particles with their natural receptors was still retained.
The major obstacle to generating newly targeted adenoviruses that have
simultaneously lost their original tropism is the trimeric nature of
the fiber protein. A trimerized fiber protein is absolutely required
for the incorporation of the fiber into the virus particle, for the
binding to penton base (44), and for the interaction with
the cellular receptors. While some specific locations in the fiber
protein have been found to be accessible for modification, most
mutations heavily disturb its three-dimensional structure. For example,
addition of 24 amino acids (aa) containing the gastrin-releasing peptide at the C-terminal end of the fiber did not prevent fiber trimerization (43) and allowed the generation of viable
viruses (our unpublished data). Similarly, addition at the same
location of peptides of various lengths (17, 21, or 32 aa) was also
shown to yield viable viruses (64). In contrast, insertions
of peptides of 26 aa (64) or 27 aa (29, 64) were
found to fully abrogate the trimerization of the fiber protein
(29) and to prevent the generation of viable viruses
(64). These data suggest that the sequence of the targeting
peptide rather than its absolute length is critical for successful
insertion at the fiber C terminus. Although the fiber HI loop was
recently shown to be a potential second site for the insertion of
foreign peptides (34), no mutation that completely abolishes
the interaction of the fiber with its cellular receptors without
altering its three-dimensional structure has been yet identified
(references 29, 48, and 64 and
our unpublished data). The generation of a truly redirected adenovirus vector would therefore require the prior identification of such a
putative sequence responsible for binding to the cell and whose mutation does not disturb the structural properties of the fiber.
We describe here an alternative strategy in which the abrogation of the
interaction between fiber and its receptors is obtained by the
generation of adenovirus particles completely devoid of fiber proteins.
The analysis of these fiberless viral species confirms that fiber is
dispensable for particle formation but is absolutely necessary for the
production of fully infectious and correctly assembled virions. The
impact of these findings on the design of targeted vectors is discussed.
 |
MATERIALS AND METHODS |
Construction of fiber deletion viral genomes.
All cloning
steps were performed by using standard molecular biology techniques
(46). The large deletion of the fiber-coding sequences (from
nucleotide [nt] 31042 to 32787 [throughout this paper, Ad5
nucleotide numbering is according to reference 10]) was obtained by ligation of two PCR amplification products. The first
PCR product extends from nt 30564 to 31041 and was generated by using
the OTG7171 (5'-atggttaacttgcaccagtgc-3') and OTG7155 (5'-gggaagcttctgcaacaacatgaagat-3')
oligonucleotide primers. The second PCR product extends from nt
32788 to 33099 and was generated by using the OTG7048
(5'-gggaagcttagaatcgtttgtgttatgttt-3') and OTG7049 (5'-ctgcccggggagtttattaat-3') primers. The two
products were then restricted with HindIII (sites are
underlined) and ligated. The small deletion in the fiber gene (from nt
31042 to 31128) was similarly generated by ligation of two PCR
products: the first product extends from nt 30564 to 31041 and was
produced by using the OTG7171 and OTG7275
(5'-gggctcgagctgcaacaacatgaagat-3') primers, and
the second fragment extends from nt 31129 to 33099 and was produced by
using the OTG7276 (5'-ccgctcgagactcctccctttgtatcc-3') and OTG7049 primers. The two products were ligated after
digestion by XhoI (sites are underlined). Reconstitution of
the fiber deletion Ad5 genomes was achieved by homologous recombination
in the Escherichia coli BJ5183 recBC sbcBC strain
(9): first, the wild-type fiber gene was replaced by the
ligated PCR products by homologous recombination with pTG8533, a
transfer plasmid bearing an Ad5 segment extending from nt 21562 to the
right-end inverted terminal repeat (ITR); second, purified
BstEII fragments (nt 24843 to 35233) containing either the
small or the large fiber deletion were introduced into the Ad5 genome
by homologous recombination with pTG3602, a plasmid containing the
full-length Ad5 genome (9). The resulting recombinant plasmids were named pAd-Fb°min (pTG4607; small deletion) and
pAd-Fb°max (pTG4608; large deletion). Plasmids pAd-LacZ/Fb°min
(pTG4629) and pAd-LacZ/Fb°max (pTG4630) were derived from
pAd-Fb°min and pAd-Fb°max, respectively, by replacing the E1 region
with a
-galactosidase expression cassette; replacement was done by
homologous recombination by cotransformation of E. coli
BJ5183 with pAd-Fb°min or pAd-Fb°max linearized by ClaI
(nt 918) and an BsrGI-PstI fragment bearing the
-galactosidase gene under the control of the major late promoter of
Ad2 and the simian virus 40 (SV40) polyadenylation signal. The
BsrGI-PstI insert was isolated from a transfer
plasmid (pTG8526) containing 17% of the viral genomic DNA (nt 1 to
6241) in which the E1 region (nt 459 to 3328) was replaced with the
-galactosidase expression cassette.
Construction of an expression plasmid for the fiber gene.
The wild-type fiber gene was PCR amplified by using the OTG7208
(5'-gggctcgag
atgaagcgcgcaagaccgtc-3')
and OTG7209 (5'-gggctcgagcacaaacgattctttattct-3')
primers (the ATG initiation and TAA stop codons are in boldface).
Sequences upstream of the start codon were modified to a more favorable
translational environment (double underline) according to Kozak
(33). Restriction of the amplified product by
XhoI (sequence underlined) and cloning into the pTG5355
eucaryotic expression vector generated plasmid pCMV-Fb (pTG4604) with
the fiber gene under the control of the human cytomegalovirus (CMV)
immediate-early promoter (CMVpro) and the rabbit
-globin splicing
and polyadenylation signals. The same plasmid also carries an
expression cassette for the hygromycin B phosphotransferase gene.
Transient-trans-complementation experiments.
Five micrograms of the fiber-modified viral genomes (pAd-Fb°min,
pAd-Fb°max, pAd-LacZ/Fb°min, and pAd-LacZ/Fb°max) was excised from the plasmid backbone by PacI digestion and transfected
into 293 cells (25) in the presence or absence of various
concentrations of the fiber-expressing plasmid (pCMV-Fb). The cells
were then either overlaid 24 h later with a solution of Dulbecco
modified Eagle medium (DMEM), 2% fetal calf serum (FCS), and 1% agar
to allow plaque formation or recovered at 9 days posttransfection for
further analysis. The presence of infectious virions in the cell
extracts was determined by incubating 20 µl of the cell extracts with
fresh 293 cells followed by Southern blot analysis of the viral DNA
accumulated at 1, 2, 4, and 8 days postincubation, using a
32P-labelled oligonucleotide probe (OTG7436,
5'-gaatgtcagtttcctcct-3' [nt 30983 to 31000]). Viral DNA
was extracted by the Hirt method (20). Alternatively, 293 cells were examined at 24 h postinfection for
-galactosidase
expression by X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) staining (47).
Generation of 293 fiber complementation cell lines.
293
cells (106) were transfected by the standard calcium
phosphate precipitation method (26) with 10 µg of the
pCMV-Fb expression plasmid. Stably transfected cells were selected by
addition of hygromycin (Boehringer Mannheim, Meynan, France) at a
concentration of 350 µg/ml. Resistant clones were isolated and
expanded for further analysis. Expression of the fiber protein was
monitored by immunofluorescence staining with a rabbit antiknob
polyclonal antibody (kindly provided by R. Gerard
[28]) diluted 1:100 in phosphate-buffered saline
(PBS). The second antibody was a DTAF-conjugated-F(ab')2 donkey anti-rabbit immunoglobulin G (Jackson Immuno Research
Laboratories, Baltimore, Md.) diluted 1:50 in PBS. The fiber-expressing
293 clones were also tested for their ability to rescue fiberless viruses after infection with viruses produced on 293 cells transiently cotransfected with the pAd-Fb°min and pCMV-Fb plasmids.
Viral growth and titration.
Virus plaques were generated by
transfection of 293 or 293-Fb cells with 10 µg of
PacI-restricted plasmids containing the full-length
adenovirus genomes, as previously described (9). Virus
amplification, titration, and storage were as described previously
(24). The virus particle concentration (particles per
milliliter) was measured by optical density (1 U of optical density at
260 nm corresponds to 1.1 × 1012 particles/ml),
infectious titers (infectious units [IU] per milliliter) were
determined at 16 to 20 h postinfection of 293 cells by staining for
-galactosidase expression or for expression of the viral DNA
binding protein (DBP) protein (37), and titration of the particle-forming units per milliliter was performed by plaque assay on
permissive 293 or 293-Fb complementation cells (24). All
adenoviruses are named according to the numbering of the parental plasmids (e.g., transfection of plasmid pAd-Fb°min generates virus Ad-Fb°min).
Western blot analysis.
Viral particles (1010)
were diluted in 2× Laemmli buffer, incubated for 5 min at 95°C, and
loaded onto a sodium dodecyl sulfate (SDS)-12% polyacrylamide gel.
Western blot analysis was done with antiknob or anti-penton base rabbit
polyclonal antibodies (kindly provided by R. Gerard
[28] and P. Boulanger, Montpellier, France, respectively). Bound antibodies were detected by using a horseradish peroxidase-conjugated donkey antirabbit antibody according to the
instructions of the manufacturer (ECL detection kit; Amersham, Les
Ullis, France).
Electron microscopy of infected cells.
293 and 293-Fb cells
were infected with Ad-Fb°max or Ad-LacZ (54) at a
multiplicity of infection (MOI) of 10 IU/cell in DMEM-2% FCS.
Infected cells were fixed at various times postinfection with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer-2% sucrose, pH 7.2. The
cells were then harvested and treated as previously described
(50). Ultrathin sections were observed under a Philips CM120
Biotwin electron microscope at 120 kV.
Radiolabelling of adenovirus proteins.
293 or 293-Fb cells
were infected with Ad-LacZ or Ad-LacZ/Fb° at an MOI of 2 IU/cell. At
20 h postinfection, the cell culture supernatant was removed and
replaced for 1 h by a medium depleted of methionine and cysteine
(Life Technologies, Cergy-Pontoise, France) and supplemented with 2%
dialyzed FCS. The depleted medium was then replaced by a minimal volume
of the same medium containing 0.2 mCi of [35S]methionine
(Amersham) per ml. At 24, 30, and 36 h postinfection, the cells
were harvested and viral progeny was recovered by three rounds of
freezing and thawing of the infected cells. The extracts were then
loaded on CsCl gradients (24). Gradients were fractionated, and the refractive index and the radioactivity of each fraction were
measured. The labelled proteins were denatured and analyzed by
SDS-10% polyacrylamide gel electrophoresis (SDS-10% PAGE).
Kinetics of viral mRNA expression.
293 or 293-Fb cells were
infected with Ad-LacZ/Fb°min, Ad-LacZ/Fb°max, or Ad-LacZ at an MOI
of 10 IU/cell. At various times postinfection, cells were recovered,
and total RNA was extracted and analyzed by Northern blotting by
standard procedures (46). Hybridizations were performed with
specific 32P-labelled oligonucleotide probes for each gene
(E2, E4, IVa2, pIX, penton base, hexon, fiber, and protease genes and
an open reading frame [ORF] encoding a 10.7-kDa product [10.7K
ORF]).
Production and purification of the Ad5 knob in E. coli.
A DNA fragment encoding the knob and the last repeat of the
shaft was isolated by PCR from AdTG3602 (9) with the OTG7740 (5'-cggccatgggtgccattacagtaggaaac-3')
and OTG7741
(5'-gggaagcttattcttgggcaatgtatga-3') primers and cloned into the pARA13 expression plasmid
(8) by using the NcoI and HindIII
restriction sites (restriction sites are underlined; ATG initiation and
TAA stop codons are in boldface). The knob-pARA13 plasmid was
transformed into E. coli MC1061 [araD139
(ara-leu)7696 lacX74 galV galK hsr-hsm rpsL]
(23), and expression of the knob peptide was induced by
growth of the transformed bacterial clone in Luria-Bertani medium
supplemented with 0.2% arabinose (Sigma, Saint-Quentin Fallavier,
France) for 4 h (49). Purification of soluble knob
peptides was performed essentially as previously described
(28).
Competition experiments.
293 cell monolayers were incubated
for 1 h at 4°C with either PBS, purified Ad5 knob (10 µg/ml in
DMEM-2% FCS), anti-
v
5 antibodies (P1F6 1/100; Life
Technologies), or RGD peptides (4 mg/ml, or the control RGE peptide;
Life Technologies). Ad-LacZ or Ad-LacZ/Fb° was then added and left
for 24 h at 37°C, and cells were then fixed and stained for
-galactosidase expression. In parallel, the
-galactosidase
activity of solubilized cell extracts was measured in a luminometer by
using a chemiluminescence reporter assay (Clontech, Palo Alto, Calif.).
Conjugation with Polybrene.
Conjugation of Ad-LacZ/Fb° or
Ad-LacZ with Polybrene was as previously described (3). The
viruses were then added to 293 cells (25) or CHO cells (ATCC
CCL-61) at various MOIs. At 24 to 48 h postinfection, cells were
fixed and stained for
-galactosidase expression.
 |
RESULTS |
Generation of fiberless adenoviruses.
All plasmids containing
the modified full-length Ad5 genomes (Fig.
1) were constructed by homologous
recombination in E. coli (9). Plasmids
pAd-LacZ/Fb°min and pAd-LacZ/Fb°max contain the bacterial
-galactosidase gene substituted for the E1 region, while
pAd-Fb°min and pAd-Fb°max contain an intact E1 region. Deletions in
the E1 and E3 regions extended from nt 459 to 3328 and from nt 28592 to
30470, respectively. Fiber-coding sequences were fully deleted in
plasmids pAd-Fb°max and pAd-LacZ/Fb°max (from nt 31042 to 32787),
while only 86 nt (from nt 31042 to 31128) was removed in plasmids
pAd-Fb°min and pAd-LacZ/Fb°min, in order to preserve the putative
10.7K ORF in the antisense orientation from nt 31628 to 31158 (1).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1.
Structures of the adenovirus vectors and fiber
expression plasmid. All indicated adenovirus vectors are derived from
full-length adenovirus genomes cloned and manipulated in E. coli as bacterial plasmids (9). pAd contains the
wild-type Ad5 genome, while all other vectors have been modified as
described in Materials and Methods. The pCMV-Fb plasmid is an
expression vector for the Ad5 fiber in which the fiber gene is under
the control of the human CMV promoter and rabbit -globin splicing
signals. The polyadenylation signal (pA) is from SV40. This plasmid
also contains the hygromycin resistance gene (HygroR) under the control
of the SV40 promoter (SVpro) and polydenylation sequences.
|
|
The biological impact of the fiber deletions was first investigated by
transient trans-complementation experiments. Transfection of
the fiber-modified viral genomes into 293 cells did not allow the
development of any viral plaques. In contrast, cotransfection of the
fiber deletion genomes together with pCMV-Fb, an expression plasmid
carrying the fiber gene (nt 31042 to 32787) under the control of the
CMV early promoter (Fig. 1), led to the development of numerous virus
plaques at 13 days posttransfection (Table
1). Such viral plaques are not the result
of contamination by a virus that had recovered the fiber sequences by
homologous recombination in the transfected cells, since all DNA
homologies between the fiber deletion virus genomes and the fiber
sequences in the pCMV-Fb plasmid were eliminated. The absence of growth
of fiberless viruses and the ability of the fiber protein to rescue
their growth in trans were further demonstrated by analysis
of viral DNA accumulation and transgene expression (Fig.
2). No viral DNA (Fig. 2A) or LacZ expression (Fig. 2B) was found in cells treated with supernatant recovered from cells transfected with pAd-LacZ/Fb° alone. In
contrast, viral DNA and transgene expression were easily detectable
when supernatant recovered from cells transfected either with pAd
(positive control) or with both the pAd-LacZ/Fb°max and pCMV-Fb
plasmids was used. No clear differences in DNA replication and virus
generation were observed between the adenoviruses with the entire fiber
sequence deleted or with the putative 10.7K ORF preserved (data not
shown).

View larger version (111K):
[in this window]
[in a new window]
|
FIG. 2.
Infectivity of the fiberless viruses generated by
transient trans complementation. 293 cells transfected with
pAd, pAd-LacZ/Fb°max, or pAd-LacZ/Fb°max together with pCMV-Fb were
recovered 9 days later and lysed by repeated freeze-thawing. Twenty
microliters of cell extract was used to infect fresh 293 cells, which
were analyzed at 1, 2, 4, and 8 days postinfection for viral DNA
replication (A) or for -galactosidase expression (B). (B) Left
panel, 293 cells treated with extracts purified from 293 cells
transfected with pAd-LacZ/Fb°max alone; right panel, 293 cells
treated with extracts isolated from 293 cells cotransfected with
pAd-LacZ/Fb°max and pCMV-Fb.
|
|
Production of fiberless adenoviruses in 293 fiber complementation
cells.
The demonstration of an efficient transient
trans-complementation of the fiberless viruses prompted us
to generate complementation cell lines constitutively expressing the
fiber gene. 293 cells were transfected with pCMV-Fb, and 85 cell clones
were selected for resistance to hygromycin. Among them, 26 were shown
to express the Ad5 fiber (data not shown) and to complement the fiber
deletion Ad5 genomes for DNA replication and plaque formation (data not shown). These data are consistent with a recent observation that fiber
complementation cells that support the growth of ts fiber mutant adenovirus can be derived from 293 cells (56). One of these cell clones (clone 38) was selected for further analysis based on
its higher expression of the fiber protein (similar to the expression
level found in cells infected with wild-type Ad5 at an MOI of 1 [data
not shown]).
Transfection of the pAd-LacZ/Fb°max and pAd-LacZ/Fb°min plasmids
into this 293-Fb clone allowed the production of large stocks of
Ad-LacZ/Fb° containing the recombinant fiber-deletion Ad5 genome (Table 2). DNA restriction and PCR
analysis confirmed the absence of fiber DNA in such virus preparations,
excluding any possible contamination by viruses with wild-type fiber
sequences (data not shown). Analysis of Ad-LacZ/Fb° (large and small
deletions) and Ad-LacZ virions revealed that the total number of
Ad-LacZ/Fb° particles produced by the fiber complementation cell line
was roughly identical to the number of Ad-LacZ particles generated on
293 cells. Interestingly, elevated amounts of fiberless virus particles
were also obtained, suggesting that virus assembly occurs efficiently
in the absence of fiber (Table 2). However, the total number of
infectious Ad-LacZ/Fb° virions produced by 293-Fb and 293 cells was
reduced by 100- and 10,000-fold, respectively, compared to that for
Ad-LacZ (Table 2). In agreement with these observations, a comparison
of the growth kinetics of Ad-LacZ and Ad-LacZ/Fb° in 293 and 293-Fb
cells showed that the production of Ad-LacZ/Fb° infectious virions by
293-Fb and 293 cells was 100 times and 5,000 times lower, respectively,
than the production of infectious Ad-LacZ (Fig.
3). A protein analysis of purified
Ad-LacZ and Ad-LacZ/Fb° virions grown on 293 and 293-Fb cells
confirmed that similar amounts of virus particles were produced:
1010 purified Ad-LacZ and Ad-LacZ/Fb° particles contain
identical quantities of penton base proteins (Fig.
4, lower panel). As expected, no fiber
signal could be detected for the Ad-LacZ/Fb° produced in 293 cells
(Fig. 4, upper panel), confirming the absence of fiber in these virus
particles. In contrast, a substoichiometric amount of fiber protein was
found in Ad-LacZ/Fb° particles grown on 293-Fb cells compared to that
of Ad-LacZ virions (Fig. 4). This observation suggests that
complementation of the fiber deletion adenovirus genome in the fiber
complementation cell lines is suboptimal, leading to the production of
normal amounts of total adenovirus particles, among which only a small
proportion (1%) is fully infectious (Table 2). These data also
indicate that adenovirus particle assembly is efficient even in the
absence of fiber proteins, but only 1 in 105 particles is
infectious (Table 2), allowing a weak but reproducible propagation of
fiberless particles in 293 cells (Fig. 3).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Physical characteristics of the viruses lacking E1
(Ad-LacZ) or E1 and fiber produced on 293 and
293-Fb cellsa
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Growth characteristics of viruses lacking E1 or E1 and
fiber on 293 and 293-Fb cells. 293 cells and 293-Fb cells were infected
at an MOI of 1 IU/cell with Ad-LacZ or Ad-LacZ/Fb°max. Infected cells
and supernatant were harvested at 24, 48, 72, and 96 h
postinfection and were treated by three freeze-thawing cycles to
release virus particles. Titers of released viruses on 293 cells were
determined by -galactosidase staining. Each data point represents
the average for duplicate infected cultures. , 293 cells infected
with Ad-LacZ; , 293-Fb cells infected with Ad-LacZ; , 293-Fb
cells infected with Ad-LacZ/Fb°max; , 293 cells infected with
Ad-LacZ/Fb°max.
|
|

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 4.
Protein analysis of purified virus particles.
Ad-LacZ/Fb°min, Ad-LacZ/Fb°max, and Ad-LacZ (Fb) produced on 293 or
293-Fb cells were purified on cesium chloride gradients (density of
1.34 g/ml). Purified particles (1010) were subjected to
SDS-12% PAGE and transferred to nitrocellulose. Ad-LacZ particles
(108, 109, and 1010) were used as
positive controls. Filters were hybridized with either an anti-penton
base serum (lower panel) or an antifiber antibody (upper panel) and
were then treated with a secondary horseradish peroxidase-conjugated
donkey antirabbit antibody.
|
|
Assembly of adenovirus particles in the absence of fiber.
In
order to determine more precisely the role of the fiber, and the impact
of its absence, in the physical assembly of adenovirus particles,
Ad-LacZ/Fb° and Ad-LacZ labelled with [35S]methionine
were produced on both 293 and 293-Fb cells and analyzed for their
density in isopycnic cesium chloride gradients (Fig. 5). All four virus preparations were
characterized by the presence of two different types of virus
populations: a population of immature empty particles with a density of
1.30 g/ml (15) and a population of more mature virions with
the expected density of 1.34 g/ml (Fig. 5). However, the proportion of
immature to mature particles was strikingly greater for the fiberless
viruses (Fig. 5C and D). Interestingly, the growth of the fiberless
viruses on the fiber complementation cell line seemed to increase the
proportion of mature particles (Fig. 5D), in correlation with the
100-fold-increased virus infectivity determined for this virus
preparation (Table 2). These results indicate that virus assembly
occurs in the absence of fiber, but this process is probably disturbed,
leading to a significant increase in the proportion of immature
virions.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 5.
Densities of purified Ad-LacZ and Ad-LacZ/Fb° viruses.
[35S]methionine-labelled Ad-LacZ/Fb°max and Ad-LacZ
were extracted from 293 and 293-Fb cells 36 h after infection (MOI
of 2 IU/cell) and loaded on isopycnic cesium chloride gradients.
Gradients were fractionated from the top, and the individual fractions
were analyzed for radioactivity and CsCl density. (A) Ad-LacZ produced
on 293 cells; (B) Ad-LacZ produced on 293-Fb cells; (C)
Ad-LacZ/Fb°max produced on 293 cells; (D) Ad-LacZ/Fb°max virus
produced on 293-Fb cells.
|
|
The existence of efficient particle formation in the absence of fiber
was confirmed by electron microscopy analysis of 293 and 293-Fb cells
infected at an MOI of 10 IU/cell with Ad5, Ad-LacZ, or Ad-LacZ/Fb°
previously produced on 293 and 293-Fb cells, respectively (Fig.
6). Similar to cells infected with Ad5 or
Ad-LacZ, all cells infected with fiberless viruses were found to
contain numerous virus particles within the nuclear compartment at
29 h postinfection. Interestingly, these fiberless particles were
often associated with nuclear membrane structures that were not
observed in cells infected with viruses expressing the wild-type fiber
protein (Fig. 6C and D). Moreover, an abundant cytoplasmic accumulation
of virus particles was also observed in cells infected with fiberless
viruses (Fig. 6E), while this phenomenon was rare in cells infected
with Ad5 or Ad-LacZ (Fig. 6A and B and data not shown). Finally, close examination by electron microscopy of 293 or 293-Fb cells infected with
Ad-LacZ or Ad-LacZ/Fb° and harvested at various time points revealed
an acceleration of the viral replication cycle for the fiberless
viruses (data not shown). Together, these studies indicate that the
fiber protein is dispensable for particle formation but may play a
direct or indirect role in the control of the viral replication cycle
and/or in the viral particle maturation process.

View larger version (159K):
[in this window]
[in a new window]
|
FIG. 6.
Electron microscopy analysis of 293 cells infected with
fiberless viruses. 293 and 293-Fb cells were infected at an MOI of 10 IU/cell with Ad5, Ad-LacZ, and Ad-LacZ/Fb°max produced on 293-Fb
cells. Infected cells were fixed with glutaraldehyde at 29 h
postinfection, and ultrathin sections were stained with uranyl acetate.
(A) Nuclear accumulation of Ad-LacZ particles in 293 cells.
Magnification, ×20,000. (B) nuclear accumulation of Ad5 particles in
293-Fb cells. Magnification, ×20,000. (C to E) Infection of 293 (C) or
293-Fb (D and E) cells with Ad-LacZ/Fb°max leads to an important
nuclear (C and D) and cytoplasmic (E) accumulation of fiberless virus
particles. Such particles are often associated with unusual nuclear
membrane structures (arrows) (C and D). Magnifications, ×20,000 (C and
E) and ×26,000 (D). c, cytoplasm; n, nucleus; m, mitochondria; µ,
micrometer.
|
|
Maturation of the fiberless adenovirus particles.
The state of
maturation and protein content of fiberless, fiber-complemented (fiber
deletion vectors produced on 293-Fb cells), and wild-type adenovirus
particles were compared by SDS-PAGE analysis of
[35S]methionine-labelled virus preparations (Fig.
7). These virus preparations were
isolated by isopycnic cesium chloride gradients in order to purify and
analyze the infectious virus population with a density of 1.34 g/ml and
eliminate the empty particles with a density of 1.30 g/ml (Fig. 5). As
expected, no fiber protein was detectable in the purified fiberless
particles, while fiber was correctly incorporated in Ad5 and Ad-LacZ
virions. Purified Ad-LacZ/Fb° particles grown on the 293-Fb cells
were also mostly devoid of detectable fiber. These results are in
agreement with a more accurate Western blot analysis of purified virus
particles, showing an absence and a substoichiometric amount of fiber
in fiberless viruses grown on 293 and 293-Fb cells, respectively (Fig.
4). The SDS-PAGE analysis of the [35S]methionine-labelled
viruses also confirmed that the maturation of the virus particles is
slightly altered in the absence of fiber. No particular differences
between Ad-LacZ/Fb° and Ad-LacZ were observed at 24 h
postinfection. Both types of particles are still relatively immature
and contain large amounts of pVI, pVII, and pVIII precursor proteins.
However, Ad-LacZ particles progress into more mature forms at 36 h
postinfection, with a complete processing of pVI, pVII, and pVIII
proteins, while Ad-LacZ/Fb° particles remain immature. The maturation
of the fiberless particles is not improved when these viruses are grown
on 293-Fb cells, indicating that incorporation of small amounts of
fiber is not sufficient to allow correct capsid processing (Fig. 7).
This incomplete maturation of fiberless virions suggests that the
biological activity of the L3-23K protein, the adenovirus-encoded
protease responsible for the processing of the viral precursors
(11, 58), is reduced in the absence of fiber.

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 7.
Protein composition and maturation of Ad-LacZ and
Ad-LacZ/Fb°max. Ad-LacZ and Ad-LacZ/Fb°max were labelled with
[35S]methionine from 20 to 24 or from 30 to 36 h
after infection of 293 or 293-Fb cells. The labelled viruses were then
purified on cesium chloride gradients (density of 1.34 g/ml) and
analyzed by SDS-10% PAGE for protein contents and state of maturation
of the protein precursors. II, hexon; III, penton base; IIIa,
peripentonal protein; IV, fiber; V, major core protein; VI,
hexon-associated protein; VII, minor core protein; pVI, pVII, and pVIII
protein precursors for VI, VII, and VIII, respectively.
|
|
Kinetics of viral transcription in fiberless viruses.
Electron
microscopic examination of cells infected with Ad-LacZ/Fb° and
Ad-LacZ at 12, 17, 23, and 29 h postinfection showed a clear
accelerated assembly of viral particles for the fiberless vectors (data
not shown). In order to gain insight into the molecular mechanisms
responsible for this apparent accelerated viral particle formation but
impaired maturation, a kinetic analysis of the viral mRNA expression
was performed for the different early (E2 and E4), intermediate (IVa2
and IX), and late (hexon, penton base, fiber, and protease) adenovirus
transcription units. 293 and 293-Fb cells were infected at an MOI of 10 IU/cell with Ad-LacZ/Fb°min, Ad-LacZ/Fb°max, or Ad-LacZ, and viral
gene expression was analyzed from 2 to 48 h postinfection (Fig.
8). As expected, no fiber RNA was
detectable in cells infected with the fiberless viruses, and the order
of appearance of the early, intermediate, and late RNAs was normal.
However, no significant differences between the viruses in the kinetics
of appearance and levels of expression of the different transcription
units were observed. These data also indicate that the impaired
maturation of the fiberless virions is not a consequence of reduced
expression of the 23K protease. The only anomaly observed in cells
infected with the fiberless viruses was a stronger early expression of
the intermediate IX and IVa2 transcripts, whose encoded proteins have
been shown to regulate the activity of the virus major late promoter
(38, 39). In addition, no differences were again found
between the viruses carrying the small and large fiber deletions. The
fact that no transcript was found when the same RNAs were analyzed for
the expression of the putative 10.7K ORF indicates that this ORF is most probably not functional (data not shown).

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 8.
Kinetics of viral mRNA expression in cells infected with
fiberless viruses. 293 and 293-Fb cells were infected with Ad-LacZ,
Ad-LacZ/Fb°min, or Ad-LacZ/Fb°max at an MOI of 2 IU/cell, and total
RNA was extracted at the indicated times for analysis by Northern
blotting. 32P-labelled oligonucleotide probes specific for
the human actin transcript (to quantitate the loaded RNAs) and for each
tested viral transcript were used for hybridization. Early viral
transcription units, E1 and E4; intermediate viral transcription units,
IVa2 and IX; late viral transcription units, hexon, penton base, fiber,
and protease. Lanes: A, mock-infected 293 cells; B, mock-infected
293-Fb cells; 1, 293 cells infected with Ad-LacZ/Fb°min; 2, 293 cells
infected with Ad-LacZ/Fb°max; 3, 293 cells infected with Ad-LacZ; 4, 293-Fb cells infected with Ad-LacZ/Fb°min; 5, 293-Fb cells infected
with Ad-LacZ/Fb°max; 6, 293-Fb cells infected with Ad-LacZ.
|
|
Mechanisms of cell entry of the fiberless viruses.
Although
they are 10,000-fold less infectious than normal virions, fiberless
viruses can still transduce human cells (Table 2). In order to
characterize their mechanism of cell entry, 293 cells were infected
with fiberless viruses, fiber-complemented viruses, or wild-type
viruses in the presence or absence of molecules that specifically block
the fiber-receptor or the penton base-integrin interactions (28,
31, 59) (Fig. 9). As expected,
addition of soluble Ad5 knob at 10 µg/ml efficiently neutralized all
fiber-bearing viruses but did not inhibit infection with fiberless
virions (Fig. 9A). In contrast, infection with fiberless or
fiber-bearing viruses was similarly inhibited by addition of the GRGDSP
peptide, indicating that the cellular entry of the fiberless virions is
mediated by the interaction of the penton base with the
v
3 and
v
5 integrins. The reduced viral sensitivity of cells treated with
the anti-
v
5 integrin P1F6 monoclonal antibody further supports
this conclusion (Fig. 9B). Addition of a control GRGESP peptide that
does not bind to the cellular integrins had no effect on infection of
293 cells (Fig. 9B). These data also suggest that the absence of fiber does not impair the ability of the penton base to bind to cellular integrins.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 9.
Mechanisms of infection of human cells by fiberless,
fiber-complemented, and wild-type viruses. 293 cells were incubated for
1 h at 4°C with saturating concentrations of Ad5 knob to block
the Ad5 cell receptor (A) or with the P1F6 monoclonal antibody to block
the cellular v 5 integrins or increasing amounts of the RGD
peptides (0.05 to 4 mg/ml) to block all v integrins (B). The
nonactive RGE peptide was used as a control. Ad-LacZ (black bars),
Ad-LacZ/Fb°max purified on 293 cells (white bars), or
Ad-LacZ/Fb°max purified on 293-Fb cells (stippled bars) was then
added at the appropriate dilution. At 24 h postinfection, the
-galactosidase activity of the cells lysates was monitored as
described in Materials and Methods. Infection efficiency is expressed
as the percentage of the -galactosidase activity in the absence of
competitor (cont.).
|
|
The reduced viral infectivity of the fiberless particles (Table 2)
could be a direct consequence of the elimination of the high-affinity
interactions between the fiber and its cellular receptors or,
alternatively, could be due to deficient biological steps later in the
viral entry process. To address this issue, we compared the abilities
of fiberless viruses, fiber-complemented viruses, and wild-type viruses
to transduce CHO cells lacking the receptors for the Ad5 fiber (5,
48, 51) (Fig.
10). In the absence
of fiber receptors, fiberless and fiber-bearing viruses should use the
same pathway to enter CHO cells, as supported by the observation that
addition of Ad5 knob did not inhibit the infection of these cells by
any of the tested viruses (Fig. 10A). However, these experiments also
show that CHO cells were 100-fold less sensitive to fiberless viruses
than to normal viruses (Fig. 10B), suggesting that the reduced
infectivity of fiberless virions is not only the consequence of their
poor efficiency of binding to the cells. In parallel, the observation
that 293 cells were 10,000-fold less sensitive to fiberless viruses
than to nonmodified viruses (Fig. 10B; Table 2) supports the hypothesis
that the reduced infectivity of the fiberless viruses is a consequence
of both the absence of fiber-receptor interactions and an alteration of a later step in the cell entry process. This hypothesis is further supported by the demonstration that infectivity of Ad-LacZ/Fb° towards CHO cells can be increased 5-fold by addition of Polybrene, a
polycation known to improve the interactions of viruses with cell
membranes (3), while infectivity of normal viruses was increased 80-fold (Fig. 10C). As expected, no increase of infectivity was observed for Ad-LacZ on 293 cells, which are known to express high
levels of the adenovirus receptors, while a fivefold increase was again
found for the fiberless viruses (Fig. 10C). Together, these data
suggest that fiberless viruses are less infectious as a consequence of
both an absence of efficient binding to the cells and an impaired cell
entry pathway.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 10.
Mechanisms of infection of cells expressing or lacking
the fiber receptors by fiberless, fiber-complemented, and wild-type
viruses. (A) Neutralization of the fiber receptors. 293 and CHO cells
(lacking the receptors for Ad5) were incubated for 30 min at 37°C
with saturating concentrations of Ad5 knob; Ad-LacZ, Ad-LacZ/Fb°max
purified on 293-Fb cells (Ad-Lac/Fb°-C), or Ad-LacZ/Fb°max was then
added at the appropriate dilution. At 24 h (293 cells) and 48 h (CHO cells) postinfection, the cells were stained for
-galactosidase expression. The efficiency of infection was expressed
as the percentage of -galactosidase positive cells in absence of knob. Black bars, control without knob; white
bars, presence of knob). (B) Viral sensitivity of 293 cells and CHO
cells. 293 cells and CHO cells were incubated with a multiplicity of
infection of 10 and 104 particles, respectively, of
Ad-LacZ, Ad-Lac/Fb°-C, or Ad-LacZ/Fb°max purified on 293 cells. The
percentage of infected cells was determined by X-Gal staining at
24 h (293 cells) and 48 h (CHO cells) postinfection. (C)
Influence of Polybrene on virus infectivity. In order to optimize the
attachment of the virus particles to the cell membranes, 293 and CHO
cells were incubated with Ad-LacZ, Ad-LacZ/Fb°max-C, or
Ad-LacZ/Fb°max in the presence or absence of Polybrene at 4 µg/ml.
At 48 h postinfection, the cells were stained for
-galactosidase expression and -galactosidase positive cells were
counted to determine the influence of Polybrene on virus infectivity.
|
|
 |
DISCUSSION |
Adenoviruses are characterized by a number of features that make
them attractive tools for in vivo gene therapy (32). In particular, they are able to efficiently infect most quiescent and
dividing human cells. However, this broad host range also constitutes a
disadvantage in some specific applications, such as the transfer of
genes encoding immunomodulatory or toxic proteins into tumor cells
(7, 22, 65). Specifically redirecting the natural tropism of
adenovirus vectors to cancer tissues should therefore significantly
reduce the toxicity and increase the efficiency of anticancer gene
therapy treatments by concentrating the vectors in the tumor area.
Moreover, redirected adenoviruses may also be useful in achieving
improved transduction of particular cell types (e.g., hematopoietic,
endothelial, or smooth muscle cells) that express low levels of the
fiber receptors on their surfaces (31, 60). Therefore, the
utility of adenovirus vectors for gene therapy can theoretically be
improved by the development of viruses specifically altered in their
natural cellular tropism.
Redirecting the adenovirus cellular specificity requires the abrogation
of the natural interaction of the fiber with its receptors and
provision of a novel binding specificity to the virus particles. While
this can be indirectly achieved by conjugating the virus with
bispecific molecules that simultaneously neutralize the viral knob and
bind to a selected cell surface marker (16, 21, 57), all
attempts to directly genetically manipulate the capsid proteins have
failed (29, 34, 35, 43, 52, 60, 64); to date, no specific
fiber sequences whose mutation would abolish the binding of the fiber
to its cellular receptors without preventing its trimerization and/or
incorporation in the virus particle have been identified. Consequently,
all reported insertions of novel nonviral ligands in the adenovirus
fiber led to the generation of vectors with an extended, and not a more
restricted, tropism (32, 35, 52, 60, 64).
Since the most radical way to prevent the binding of the virus to its
receptors consists of the complete elimination of the fiber from the
viral particles, we attempted to generate fiberless virions that could
then be used as substrates for the incorporation of an exogenous ligand
at another location in the virus capsid. Successful insertions of
exogenous DNA sequences into the penton base or the hexon genes were
already reported (12, 62), and the possibility of generating
fiberless virus particles was previously suggested by Falgout and
Ketner (18). Those authors reported in 1988 that expression
of the fiber gene was nonessential for virion assembly. However, their
observation was weakened by the presence in the fiberless virus stocks
of low levels of contamination (0.1 to 0.8%) of a helper virus with a
wild-type fiber gene (17, 18). Using our previously
described method for the manipulation of the cloned full-length Ad5
genome by homologous recombination in E. coli
(9), we generated a viral genome with the whole fiber-coding
sequence precisely deleted and analyzed the biological properties of
the corresponding virus. Since a previous report suggested the
existence in the antisense orientation of a putative 10.7K ORF
overlapping the fiber gene (1), we also generated a viral
genome in which the fiber gene was partially deleted but in which the
10.7K ORF was preserved.
We report here that introduction of a cloned Ad5 genome with the E1 and
fiber genes deleted into 293 cells or 293 cells stably expressing the
fiber in trans leads to the intracellular accumulation of
large amounts of fiberless virus capsids. Such particles are unable to
propagate in 293 cells, while propagation is restored in 293-Fb
complementation cells. Given the fact that a cloned full-length virus
genome was used to generate these particles, these results confirm
without any ambiguity that the fiber protein is dispensable for virus
particle formation but is necessary for efficient virus propagation.
Analysis of the virus particles by isopycnic cesium chloride gradients
and electron microscopy provided further evidence that formation of
adenovirus capsids is efficient in the absence of fiber: accumulation
of large quantities of fiberless virus particles of the expected
density (1.34 g/ml) was found in the nuclei of 293 cells. However,
these experiments also revealed some intriguing abnormalities. (i)
While virus assembly was exclusively nuclear for the viruses with
wild-type fiber sequences, a massive cytoplasmic accumulation of virus
particles was observed for the fiberless capsids; moreover, these
fiberless viruses were often associated with abnormal nuclear membrane
structures. (ii) The proportion of immature particles with a density of
1.30 g/ml was greatly increased in the purified preparations of
fiberless viruses compared to viruses with a wild-type fiber gene.
(iii) An SDS-PAGE protein analysis of purified viruses with a density
of 1.34 g/ml showed that the processing of the viral pVI, pVII, and
pVIII precursor proteins was much less effective in the fiberless
particles, leading to the accumulation of mostly immature viruses; this
result is in agreement with an earlier observation by Falgout and
Ketner, who reported that viruses lacking the fiber gene and segments of either E3 or E4 regions contain poorly processed precursors (18). (iv) Despite clearly impaired maturation of the
fiberless particles, the adenovirus L3 transcription unit encoding the
23K protease responsible for the processing of the viral precursors (58) is correctly expressed. (v) A detailed analysis of
fiberless virus particles produced on 293 cells shows that only 1 of
105 purified fiberless particles is infectious, compared to
1 of 10 for the vectors with wild-type fiber sequences; providing the fiber protein in trans partially restores the infectivity,
since 1 of 103 purified fiberless particles is infectious
when grown on the 293-Fb complementation cell line.
These results confirm that virus assembly is efficient in the absence
of fiber but also indicate that fiber has additional functions besides
its role in the stabilization of the viral capsid and binding to
cellular receptors. These observations, together with the demonstration
that the 23K protease is required for virus entry into host cells
(11, 27), raised the question whether the 10,000-fold
reduction in infectivity of the fiberless viruses is only a consequence
of the inability of the virions to bind to the cells or whether other
biological events involved in the cell entry process were also
affected. To address this issue, the mechanisms of binding to and
infection of 293 cells (expressing Ad5 receptors) and CHO cells
(lacking Ad5 receptors) (5, 48, 51) were analyzed by using
specific competitors for binding to the fiber receptors or to the
cellular integrins. These studies showed that the residual infectivity
of the fiberless viruses is mediated by the direct interaction of the
penton base with the
v
3 and
v
5 cellular integrins,
triggering virus entry into the cells. Given the lower affinity of the
penton base-integrins interaction than of the fiber-receptor
interaction (59), the reduced infectivity of the fiberless
viruses is therefore, at least in part, the consequence of the absence
of fiber. However, experiments using CHO cells demonstrated that an
additional block at a later stage of infection also significantly
reduces the infectivity of these fiberless viruses. Although CHO cells
lack Ad5 receptors and should be equally sensitive to fiberless and
wild-type viruses, fiberless viruses are still 100-fold less infectious
than viruses with wild-type fiber sequences. Moreover, fiberless
viruses grown on 293-Fb complementation cells (which have therefore
incorporated substoichiometric amounts of fiber proteins) have a
10-fold-increased infectivity towards the CHO cells compared to
fiberless viruses grown on 293 cells. Finally, the efficiency of
infection of CHO cells by wild-type control viruses could be increased
by 80-fold when the attachment of the virus particles to the cell
membrane was improved by addition of Polybrene (3). In
contrast, only 5- and 10-fold increases were observed for the fiberless
viruses and the fiberless viruses grown on 293-Fb cells, respectively. This modest improvement in the efficiency of infection by the fiberless
viruses supports the hypothesis that the reduced infectivity of these
viruses is not only due to the absence of attachment to the cells but
that later stages in the virus entry process are also impaired.
Together, these data demonstrate that fiber not only is essential for
the high-affinity binding of the virions to their target cells but is
also necessary for the correct maturation of the virus particles. The
fact that the L3 transcription unit encoding the 23K protease is
expressed at normal levels in cells infected with the fiberless viruses
suggests that the biological activity, and not the expression of the
protease, is altered in the absence of fiber. Further studies are in
progress to investigate the relationship between the fiber, the
protease, and the virus maturation process. Finally, these data also
stress the fact that these fiberless viruses may become interesting
candidates for the development of novel targeted gene transfer vectors
if their infectivity can be restored to near-normal levels. Such
fiberless viruses may indeed constitute targeted gene transfer vectors
on their own, given their ability to specifically bind to the cellular
v
3 or
v
5 integrins.
v integrins are selectively
expressed on the surfaces of some tumor cell types (2, 19)
and on tumor blood vessels (42), and
v
3 integrins have
been shown to be preferentially expressed on vascular endothelial cells
and smooth muscle cells at sites of atherosclerotic lesions (4,
53). These viruses are thus potential candidates for cancer and
cardiovascular gene therapy applications. Alternatively, fiberless
viruses with a restored infectivity would also constitute ideal
substrates for the addition of selected novel nonviral ligands into
other capsid proteins (e.g., hexon or penton base). A better
understanding of the mechanisms responsible for the altered maturation
of the fiberless virions is therefore necessary in order to correct the processing of the structural proteins and improve the viral infectivity.
 |
ACKNOWLEDGMENTS |
We are grateful to P. Boulanger and R. Gerard for the gifts of
the anti-penton base and antiknob polyclonal antibodies, respectively. We thank F. Puvion-Dutilleul for expert advice and R. Rooke, L. Grave,
M. Lusky, and M. Courtney for critical reading of the manuscript.
This work was supported in part by the Convention Industrielle pour la
Formation par la Recherche CIFRE (grant 512/94), by the Association
Française contre la Mucoviscidose (AFLM) and by the Association
Française contre les Myopathies (AFM).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Transgène
S.A., 11 rue de Molsheim, 67000 Strasbourg, France. Phone: (33) 388 27 91 68. Fax: (33) 388 27 91 11. E-mail: mehtali{at}transgene.fr.
 |
REFERENCES |
| 1.
|
Akusjärvi, G., and G. Wadell.
1987.
Genetic maps of human and animal adenoviruses, p. 78-85.
In
S. J. O'Brien (ed.), Genetic maps 1987, a compilation of linkage and restriction maps of genetically studied organisms, vol. 4. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 2.
|
Albelda, S. M.,
S. A. Mette,
D. E. Elder,
R. Stewart,
L. Damjanovich,
M. Herlyn, and C. A. Buck.
1990.
Integrin distribution in malignant melanoma: association of the 3 subunit with tumor progression.
Cancer Res.
50:6757-6764[Abstract/Free Full Text].
|
| 3.
|
Arcosoy, S. M.,
J. D. Latoche,
M. Gondor,
B. R. Pitt, and J. M. Pilewski.
1997.
Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro.
Gene Ther.
4:32-38[Medline].
|
| 4.
|
Assoian, R., and E. Marcantonio.
1997.
The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.
J. Clin. Invest.
100:S15-S18.
|
| 5.
|
Bergelson, J. M.,
J. A. Cunningham,
G. Droguett,
E. A. Kurt-Jones,
A. Krithivas,
J. S. Hong,
M. S. Horwitz,
R. L. Crowell, and R. W. Finberg.
1997.
Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5.
Science
275:1320-1323[Abstract/Free Full Text].
|
| 6.
|
Bramson, J.,
F. Graham, and J. Gauldie.
1995.
The use of adenoviral vectors for gene therapy and gene transfer in vivo.
Curr. Opin. Biotechnol.
6:590-595[Medline].
|
| 7.
|
Bui, L. A.,
L. H. Butterfield,
J. Y. Kim,
A. Ribas,
P. Seu,
R. Lau,
J. A. Glaspy,
W. H. McBride, and J. S. Economou.
1997.
In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.
Hum. Gene Ther.
8:2173-2182[Medline].
|
| 8.
|
Cagnon, C.,
V. Valverde, and J. Masson.
1991.
A new family of sugar-inducible expression vectors for Escherichia coli.
Prot. Eng.
4:843-847[Abstract/Free Full Text].
|
| 9.
|
Chartier, C.,
E. Degryse,
M. Gantzer,
A. Dieterle,
A. Pavirani, and M. Mehtali.
1996.
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.
J. Virol.
70:4805-4810[Abstract].
|
| 10.
|
Chroboczek, J.,
F. Bieber, and B. Jacrot.
1992.
The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2.
Virology
186:280-285[Medline].
|
| 11.
|
Cotten, M., and J. M. Weber.
1995.
The adenovirus protease is required for virus entry into host cells.
Virology
213:494-502[Medline].
|
| 12.
|
Crompton, J.,
C. I. Toogood,
N. Wallis, and R. T. Hay.
1994.
Expression of a foreign epitope on the surface of the adenovirus hexon.
J. Gen. Virol.
75:133-139[Abstract/Free Full Text].
|
| 13.
|
Crystal, R. G.
1995.
Transfer of genes to humans: early lessons and obstacles to success.
Science
270:404-410[Abstract/Free Full Text].
|
| 14.
|
Defer, C.,
M.-T. Belin,
M.-L. Caillet-Boudin, and P. Boulanger.
1990.
Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.
J. Virol.
64:3661-3673[Abstract/Free Full Text].
|
| 15.
|
D'Halluin, J.-C.
1995.
Virus assembly, p. 47-66.
In
W. Doerfler, and P. Böhm (ed.), The molecular repertoire of adenoviruses I virion structure and infection. Springer-Verlag, Berlin, Germany.
|
| 16.
|
Douglas, J.,
B. Rogers,
M. Rosenfeld,
S. Michael,
M. Feng, and D. Curiel.
1996.
Targeted gene delivery by tropism-modified adenoviral vectors.
Nat. Biotechnol.
14:1574-1578[Medline].
|
| 17.
|
Falgout, B., and G. Ketner.
1987.
Adenovirus early region 4 is required for efficient virus particle assembly.
J. Virol.
61:3759-3768[Abstract/Free Full Text].
|
| 18.
|
Falgout, B., and G. Ketner.
1988.
Characterization of adenovirus particles made by deletion mutants lacking the fiber gene.
J. Virol.
62:622-625[Abstract/Free Full Text].
|
| 19.
|
Gladson, C. L., and D. A. Cheresh.
1991.
Glioblastoma expression of vitronectin and the v 3 integrin: adhesion mechanism for transformed glial cells.
J. Clin. Invest.
88:1924-1932.
|
| 20.
|
Gluzman, Y., and K. van Doren.
1983.
Palindromic adenovirus type 5-simian virus 40 hybrid.
J. Virol.
45:91-103[Abstract/Free Full Text].
|
| 21.
|
Goldman, C. K.,
B. E. Rogers,
J. T. Douglas,
B. A. Sosnowski,
W. B. Ying,
G. P. Siegal,
A. Baird,
J. A. Campain, and D. T. Curiel.
1997.
Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor.
Cancer Res.
57:1447-1451[Abstract/Free Full Text].
|
| 22.
|
Goodman, J.,
T. Trask,
S.-H. Chen,
S. Woo,
R. Grossman,
K. Carey,
G. Hubbard,
D. Carrier,
S. Rajagopalan,
E. Aguilar-Cordova, and H. Shine.
1996.
Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies.
Hum. Gen. Ther.
7:1241-1250[Medline].
|
| 23.
|
Gough, J., and N. Murray.
1983.
Sequence diversity among related genes for recognition of specific targets in DNA molecules.
J. Mol. Biol.
166:1-19[Medline].
|
| 24.
|
Graham, F., and L. Prevec.
1991.
Manipulation of adenovirus vectors.
Methods Mol. Biol.
7:109-128.
|
| 25.
|
Graham, F.,
J. Smiley,
W. Russell, and R. Nairn.
1977.
Characteristics of a human cell line transformed by DNA from human Ad5.
J. Gen. Virol.
75:133-139.
|
| 26.
|
Graham, F., and A. Van der Eb.
1973.
A new technique for the assay of infectivity of human adenovirus 5 DNA.
Virology
52:456-467[Medline].
|
| 27.
|
Greber, U. F.,
P. Webster,
J. Weber, and A. Helenius.
1996.
The role of the adenovirus protease in virus entry into cells.
EMBO J.
15:1766-1777[Medline].
|
| 28.
|
Henry, L.,
D. Xia,
M. Wilke,
J. Deisenhofer, and R. Gerard.
1994.
Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli.
J. Virol.
68:5239-5246[Abstract/Free Full Text].
|
| 29.
|
Hong, J., and J. Engler.
1996.
Domains required for assembly of adenovirus type 2 fibers trimers.
J. Virol.
70:7071-7078[Abstract/Free Full Text].
|
| 30.
|
Hong, S. S.,
L. Karayan,
J. Tournier,
D. T. Curiel, and P. A. Boulanger.
1997.
Adenovirus type 5 fiber knob binds to MHC class I 2 domain at the surface of human epithelial and B lymphoblastoid cells.
EMBO J.
16:2294-2306[Medline].
|
| 31.
|
Huang, S.,
T. Kamata,
Y. Takada,
Z. Ruggeri, and G. Nemerow.
1996.
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.
J. Virol.
70:4502-4508[Abstract].
|
| 32.
|
Kovesdi, I.,
D. E. Brough,
J. T. Bruder, and T. J. Wickham.
1997.
Adenoviral vectors for gene transfer.
Curr. Opin. Biotechnol.
8:583-589[Medline].
|
| 33.
|
Kozak, M.
1986.
Influences of mRNA secondary structure on initiation by eukaryotic ribosomes.
Proc. Natl. Acad. Sci. USA
83:2850-2854[Abstract/Free Full Text].
|
| 34.
|
Krasnykh, V.,
I. Dmitriev,
G. Mekheeva,
C. R. Miller,
N. Belousova, and D. T. Curiel.
1998.
Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob.
J. Virol.
72:1844-1852[Abstract/Free Full Text].
|
| 35.
|
Krasnykh, V.,
G. Mikheeva,
J. Douglas, and D. Curiel.
1996.
Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.
J. Virol.
70:6839-6846[Abstract/Free Full Text].
|
| 36.
|
Louis, N.,
P. Fender,
A. Barge,
P. Kitts, and J. Chroboczek.
1994.
Cell binding domain of adenovirus serotype 2 fiber.
J. Virol.
68:4104-4106[Abstract/Free Full Text].
|
| 37.
|
Lusky, M.,
M. Christ,
K. Rittner,
A. Dieterle,
D. Dreyer,
B. Mourot,
H. Schutz,
F. Stoeckel,
A. Pavirani, and M. Mehtali.
1998.
In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.
J. Virol.
72:2022-2032[Abstract/Free Full Text].
|
| 38.
|
Lutz, P., and C. Kedinger.
1996.
Properties of the adenovirus Iva2 gene product, an effector of late-phase-dependent activation of the major late promoter.
J. Virol.
70:1396-1405[Abstract].
|
| 39.
|
Lutz, P.,
M. Rosa-Calatrava, and C. Kedinger.
1997.
The product of the adenovirus intermediate gene IX is a transcriptional activator.
J. Virol.
71:5102-5109[Abstract].
|
| 40.
|
Marcel, T., and J. D. Grausz.
1997.
The TMC worldwide gene therapy enrollment report, end 1996.
Hum. Gen. Ther.
8:775-800[Medline].
|
| 41.
|
Mathias, P.,
T. Wickham,
M. Moore, and G. Nemerow.
1994.
Multiple adenovirus serotypes use v integrins for infection.
J. Virol.
68 |